Science Explorer Back to mapMap

Most cited papers from Medical Radiological Research Center

What are the most cited papers from Medical Radiological Research Center?

The most cited paper from Medical Radiological Research Center is "Duration of Androgen Suppression in the Treatment of Prostate Cancer" (M. Bolla, Theodorus M. de Reijke, Geertjan van Tienhoven et al., 2009), with 977 citations. Next come "Necrosis: a specific form of programmed cell death?" (721) and "Risk of Thyroid Cancer After Exposure to 131 I in Childhood" (594).

Showing 50 of 59 papers. Every paper with more than 82 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Duration of Androgen Suppression in the Treatment of Prostate Cancer M. Bolla, Theodorus M. de Reijke, Geertjan van Tienhoven et al. · New England Journal of Medicine Open access 10 Jun 2009 977
2 Necrosis: a specific form of programmed cell death? Sergey Proskuryakov, Anatoli G Konoplyannikov, Vladimir L. Gabai · Experimental Cell Research Feb 2003 721
3 Risk of Thyroid Cancer After Exposure to 131 I in Childhood Elisabeth Cardis et al. · JNCI Journal of the National Cancer Institute 17 May 2005 594
4 Induction of oxyradicals by arsenic: Implication for mechanism of genotoxicity Su X. Liu, Mohammad Athar, István Lippai et al. · Proceedings of the National Academy of Sciences Open access 6 Feb 2001 539
5 Hsp70 Prevents Activation of Stress Kinases Vladimir L. Gabai, Anatoli B. Meriin, Dick D. Mosser et al. · Journal of Biological Chemistry Open access Jul 1997 511
6 Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial Matthew R. Smith et al. · The Lancet Oncology Open access 10 Feb 2019 412
7 BRAF mutations are associated with some histological types of papillary thyroid carcinoma Vítor Trovisco, Inês Vieira de Castro, Paula Soares et al. · The Journal of Pathology 19 Jan 2004 368
8 Systematic Review and Meta-analysis of Circulatory Disease from Exposure to Low-Level Ionizing Radiation and Estimates of Potential Population Mortality Risks Mark P. Little et al. · Environmental Health Perspectives ReviewOpen access 22 Jun 2012 368
9 Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer Sunil R. Hingorani, William Proctor Harris, Joseph Thaddeus Beck et al. · Clinical Cancer Research Open access 26 Jan 2016 330
10 Proteasome Inhibitors Activate Stress Kinases and Induce Hsp72 Anatoli B. Meriin, Vladimir L. Gabai, Julia A. Yaglom et al. · Journal of Biological Chemistry Open access Mar 1998 302
11 Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial Ian F. Tannock et al. · The Lancet Oncology 3 Jun 2013 289
12 Zinc in the human prostate gland: Normal, hyperplastic and cancerous V. Ye. Zaichick, Tatiana V. Sviridova, Sofia Zaichick · International Urology and Nephrology Sep 1997 265
13 Cancer consequences of the Chernobyl accident: 20 years on Elisabeth Cardis et al. · Journal of Radiological Protection 24 Apr 2006 246
14 Phase 3 Trial of Selpercatinib in Advanced RET -Mutant Medullary Thyroid Cancer Julien Hadoux et al. · New England Journal of Medicine 21 Oct 2023 207
15 Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials Jeremy G. Franklin et al. · Annals of Oncology ReviewOpen access 19 Sep 2006 189
16 Hsp70–Bag3 Interactions Regulate Cancer-Related Signaling Networks Teresa A. Colvin, Vladimir L. Gabai, Jianlin Gong et al. · Cancer Research Open access 4 Jul 2014 187
17 Accumulation of rare earth elements in human bone within the lifespan Sofia Zaichick, Vladimir Zaichick, В. К. Карандашев et al. · Metallomics 21 Dec 2010 186
18 THE RISK OF RADIATION-INDUCED CEREBROVASCULAR DISEASE IN CHERNOBYL EMERGENCY WORKERS V.K. Ivanov, М.А. Maksioutov, Sergey Yu. Chekin et al. · Health Physics 3 Feb 2006 183
19 BRAFMutations Are Not a Major Event in Post-Chernobyl Childhood Thyroid Carcinomas Jorge Pereira Lima, Vítor Trovisco, Paula Soares et al. · The Journal of Clinical Endocrinology & Metabolism Open access Sep 2004 182
20 Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside Xuhui Bao, Yongjun Liang, Hanman Chang et al. · Signal Transduction and Targeted Therapy Open access 7 Jan 2024 179
21 The Chernobyl Accident and its Consequences Vladimir Saenko, V.K. Ivanov, Anatoli F. Tsyb et al. · Clinical Oncology Open access 23 Feb 2011 169
22 Ionising radiation and cardiovascular disease: systematic review and meta-analysis Mark P. Little, Tamara V. Azizova, David Bonner Richardson et al. · BMJ ReviewOpen access 8 Mar 2023 160
23 Cell Death and Survival Assays Alexander E. Kabakov, Vladimir L. Gabai · Methods in molecular biology Book chapter 25 Nov 2017 159
24 Hsp72-Mediated Suppression of c-Jun N-Terminal Kinase Is Implicated in Development of Tolerance to Caspase-Independent Cell Death Vladimir L. Gabai, Julia A. Yaglom, Vladimir Volloch et al. · Molecular and Cellular Biology Open access Sep 2000 158
25 Extrapineal Melatonin: Location and Role within Diffuse Neuroendocrine System Igor Moiseevich Kvetnoy · The Histochemical Journal 1999 156
26 Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing Alexander E. Kabakov, Anna O. Yakimova · Cancers Open access 4 Mar 2021 153
27 Adverse events, side effects and complications in mesenchymal stromal cell-based therapies Denis Baranovskii, Ilya Klabukov, Nadezhda V. Arguchinskaya et al. · Stem Cell Investigation Open access Nov 2022 147
28 Iodine deficiency, radiation dose, and the risk of thyroid cancer among children and adolescents in the Bryansk region of Russia following the Chernobyl power station accident V.V. Shakhtarin, А. Ф. Цыб, Valeriy F. STEPANENKO et al. · International Journal of Epidemiology Aug 2003 147
29 Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness E. D. Williams, A Abrosimov, Bogdanova Ti et al. · British Journal of Cancer Open access 11 May 2004 141
30 Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL Fritz C. Offner, Olga S. Samoilova, Evgenii A. Osmanov et al. · Blood Open access 31 Jul 2015 138
31 Medical elementology as a new scientific discipline Vladimir Zaichick · Journal of Radioanalytical and Nuclear Chemistry Aug 2006 136
32 Induction of oxyradicals by arsenic: Implication for mechanism of genotoxicity Song-Yao Liu · Proceedings of the National Academy of Sciences 6 Feb 2001 133
33 Trace elements and thyroid cancer Vladimir Zaichick, Anatoli F. Tsyb, Boris M. Vtyurin · The Analyst 1995 132
34 Increased expression of the major heat shock protein Hsp72 in human prostate carcinoma cells is dispensable for their viability but confers resistance to a variety of anticancer agents Vladimir L. Gabai, K. R. Budagova, Michael Y. Sherman · Oncogene 21 Feb 2005 130
35 Neuroendocrine differentiation in human gastric carcinoma. Helge Lyder Waldum, Steinar Aase, И. М. Кветной et al. · PubMed Aug 1998 124
36 Modulation of in Vivo HSP70 Chaperone Activity by Hip and Bag-1 Ellen A. A. Nollen, Alexander E. Kabakov, Jeanette F. Brunsting et al. · Journal of Biological Chemistry Open access Feb 2001 121
37 Risk of Thyroid Cancer in the Bryansk Oblast of the Russian Federation after the Chernobyl Power Station Accident S. Scott Davis, Valeriy F. STEPANENKO, Nikolai Rivkind et al. · Radiation Research Sep 2004 120
38 Risk of Hematological Malignancies among Chernobyl Liquidators Ausrele Kesminiene et al. · Radiation Research Open access 13 Nov 2008 119
39 Statistical Mechanics for a Class of Quantum Statistics SERGEI B. ISAKOV · Physical Review Letters 17 Oct 1994 118
40 The second international intercomparison on EPR tooth dosimetry A. Wieser et al. · Radiation Measurements Dec 2000 112
41 Impedance Spectroscopy as a Tool for Monitoring Performance in 3D Models of Epithelial Tissues T. N. Gerasimenko, Sergey V. Nikulin, Г. С. Захарова et al. · Frontiers in Bioengineering and Biotechnology Open access 23 Jan 2020 111
42 Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors Timothy Anthony Yap, Aditya Bardia, Michael Dvorkin et al. · JAMA Oncology Open access 17 Nov 2022 109
43 Kidney Injury Molecule 1 (KIM-1): a Multifunctional Glycoprotein and Biological Marker (Review) Tatyana A. Karmakova, Natalia S. Sergeeva, K. Yu. Kanukoev et al. · Современные технологии в медицине Open access Jun 2021 109
44 Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy Alexander E. Kabakov, Anna O. Yakimova, Olga N. Matchuk · Cells Open access 6 Apr 2020 109
45 Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses Paul Mitchell, N. M. Thatcher, Mark A. Socinski et al. · Annals of Oncology Open access 27 Feb 2015 109
46 Suppression of Stress Kinase JNK Is Involved in HSP72-mediated Protection of Myogenic Cells from Transient Energy Deprivation Vladimir L. Gabai, Anatoli B. Meriin, Julia A. Yaglom et al. · Journal of Biological Chemistry Open access Dec 2000 104
47 Zinc concentration in human prostatic fluid: Normal, chronic prostatitis, adenoma and cancer Vladimir Zaichick, Tatiana V. Sviridova, Sofia Zaichick · International Urology and Nephrology Sep 1996 94
48 Risk of Thyroid Cancer among Chernobyl Liquidators Ausrele Kesminiene, Anne-Sophie Evrard, V.K. Ivanov et al. · Radiation Research 21 Sep 2012 93
49 A search for losses of chemical elements during freeze-drying of biological materials Vladimir Zaichick, Sofia Zaichick · Journal of Radioanalytical and Nuclear Chemistry Apr 1997 92
50 Necrosis Is an Active and Controlled Form of Programmed Cell Death S. Ya. Proskuryakov, Vladimir L. Gabai, Anatoly Konoplyannikov · Biochemistry (Moscow) Apr 2002 92

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.